CHEMICAL-STRUCTURE AND ACTION OF ANTI-SCLEROTIC DRUGS (REVIEW OF LITERATURE)

[1] ALBRIGHT D, 1979, J PHARM SCI, V68, P936

[2] BAYLEY J, 1972, J MED CHEM, V15, P344

[3] BECKMAN R, 1972, ADV EXPTL MEDICINE B, V26, P276

[4] Bencze W L, 1969, Prog Drug Res, V13, P217

[5] BENNET GB, 1976, J MED CHEM, V19, P9

[6] MODE OF ACTION OF LIPID-LOWERING AGENTS, CLOFIBRATE AND BM-15075, ON CHOLESTEROL-BIOSYNTHESIS IN RAT-LIVER [J]. ATHEROSCLEROSIS, 1978, 30 (02) : 147 - 152

[7] BRITOV AN, 1974, ITOGI NAUKI TEKHNI F, V6, P5

[8] HYPOCHOLESTEROLEMIC 5-METHYLTETRAZOLE DERIVATIVES [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (02) : 174 - 175

[9] CARLSON LA, 1972, ACTA PHARM SUEC, V9, P289

[10] CARLSON LA, 1972, ACTA PHARM SUEC, V9, P221

[1] ALBRIGHT D, 1979, J PHARM SCI, V68, P936

[2] BAYLEY J, 1972, J MED CHEM, V15, P344

[3] BECKMAN R, 1972, ADV EXPTL MEDICINE B, V26, P276

[4] Bencze W L, 1969, Prog Drug Res, V13, P217

[5] BENNET GB, 1976, J MED CHEM, V19, P9

[6] MODE OF ACTION OF LIPID-LOWERING AGENTS, CLOFIBRATE AND BM-15075, ON CHOLESTEROL-BIOSYNTHESIS IN RAT-LIVER [J]. ATHEROSCLEROSIS, 1978, 30 (02) : 147 - 152

[7] BRITOV AN, 1974, ITOGI NAUKI TEKHNI F, V6, P5

[8] HYPOCHOLESTEROLEMIC 5-METHYLTETRAZOLE DERIVATIVES [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (02) : 174 - 175

[9] CARLSON LA, 1972, ACTA PHARM SUEC, V9, P289

[10] CARLSON LA, 1972, ACTA PHARM SUEC, V9, P221